Wall Street analysts forecast that Unum Therapeutics Inc (NASDAQ:UMRX) will report $3.76 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Unum Therapeutics’ earnings, with the highest sales estimate coming in at $4.41 million and the lowest estimate coming in at $3.11 million. Unum Therapeutics posted sales […]